SEOUL, South Korea--(BUSINESS WIRE)--Innovo Therapeutics Inc. has announced the results of its Phase 2 clinical trial demonstrating the innovative efficacy of INV-001 in scar treatment. The trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback